Chimeric antigen receptor T-cell therapy outcomes in T cell/histiocyte-rich large B-cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study
Author
Date
2025-02-04Permanent link
http://hdl.handle.net/11351/12787DOI
10.1002/hem3.70077
ISSN
2572-9241
WOS
001413884400001
PMID
39906687
Keywords
T-cell therapy; Large B-cell lymphoma; Disease progressionBibliographic citation
Bastos-Oreiro M, Iacoboni G, Garcés VN, Caballero AC, Martínez N, Delgado J, et al. Chimeric antigen receptor T-cell therapy outcomes in T cell/histiocyte-rich large B-cell lymphoma and subsequent treatment strategies after disease progression: A GELTAMO/GETH study. HemaSphere. 2025 Feb;9(2):e70077.
Audience
Professionals
This item appears in following collections
- HVH - Articles científics [4470]
- VHIO - Articles científics [1250]
The following license files are associated with this item:





